NIH-funded research NIH-funded research

Investigating how mast cells contribute to lung injury from chemical threats

Official title: Mast Cell Activation as a Common Mechanism of Pulmonary Toxicity by Chemical Threat Agents

Funded at University of Colorado Denver · NIH-10887265 · Data updated 2026-11-12

This study is looking at how certain chemicals that can harm the lungs affect special immune cells called mast cells, with the goal of finding new ways to help protect or treat lung injuries caused by things like pollution or chemical exposure.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startAugust 20, 2023
Project endJuly 31, 2025
Funding year2023
Award (this year)$462,501
NIH project number1R56ES034386-01A1
Project IDNIH-10887265 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals who have been exposed to chemical agents or those with respiratory conditions exacerbated by environmental toxins.

Less likely to help

Patients with lung injuries not related to chemical exposures or those with chronic respiratory diseases unrelated to mast cell activation may not benefit from this research.

What this research studies

This research focuses on understanding how mast cells, a type of immune cell, are activated by various chemical agents that can cause lung injury. The study aims to identify common inflammatory mechanisms triggered by these agents, which include substances like nitrogen mustard and diesel exhaust. By examining how mast cells respond to these chemicals, the research seeks to uncover potential therapeutic targets and biomarkers that could help in treating or preventing lung damage from chemical exposures. Patients may benefit from insights gained about how to better protect against or treat lung injuries caused by environmental toxins.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments and preventive measures for lung injuries caused by chemical threats.

How similar studies have gone: Previous research has shown that mast cell activation plays a significant role in lung inflammation, suggesting that this approach may yield valuable insights.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Brown, Jared Michael — University of Colorado Denver
  • Study coordinator: Brown, Jared Michael

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.